210 - Assessment of Safety and Efficacy of PBSC Mobilization with G-CSF and CD34+ Enrichment and Pbmnc (CD3+) Addback in Familial Haploidentical (FHI) Adult Donors with Sickle Cell Disease Trait (SCDT) Prior to Allogeneic HSCT of High-Risk SCD Patients

Bronwyn Long,Sandra Fabricatore,Allyson Flower,Erin Morris,Harshini Mahanti,Qiuhu Shi,Carolyn Keever-Taylor,Rona S Weinberg,Brenda Grossman,Julie-An M Talano,Shalini Shenoy,Theodore B Moore,Janet Ayello,Mildred Semidei-Pomales,Carmella Van De Ven,Mitchell S Cairo

doi:10.1016/j.bbmt.2017.12.039

210 - Assessment of Safety and Efficacy of PBSC Mobilization with G-CSF and CD34+ Enrichment and Pbmnc (CD3+) Addback in Familial Haploidentical (FHI) Adult Donors with Sickle Cell Disease Trait (SCDT) Prior to Allogeneic HSCT of High-Risk SCD Patients

Bronwyn Long, Sandra Fabricatore + Show 14 more

Open Access

https://doi.org/10.1016/j.bbmt.2017.12.039

Copy DOI

Journal: Biology of Blood and Marrow Transplantation	Publication Date: Feb 3, 2018
License type: cc-by-nc-nd

Affiliation: New York Medical College, Medical College of Wisconsin, New York Blood Center, Washington University in St. Louis, St. Louis Children's Hospital, University of California, Los Angeles

#Sickle Cell Disease Trait #Familial Haploidentical + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

210 - Assessment of Safety and Efficacy of PBSC Mobilization with G-CSF and CD34+ Enrichment and Pbmnc (CD3+) Addback in Familial Haploidentical (FHI) Adult Donors with Sickle Cell Disease Trait (SCDT) Prior to Allogeneic HSCT of High-Risk SCD Patients

Full Text